Mulvihill U.S. Health Care Enhanced Yield ETF

Historic Net Asset Value Per Unit

Portfolio Manager Updates

Fund Features

Objectives

The Mulvihill U.S. Health Care Enhanced Yield ETF seeks to provide Unitholders with long-term capital appreciation through exposure to a portfolio consisting principally of U.S. health care issuers selected from the S&P 500 Index that are classified as “health care” by Standard & Poor’s Global Industry Classification Standard and monthly cash distributions.

Investment Strategy

In order to achieve its investment objectives, the Mulvihill U.S. Health Care Enhanced Yield ETF will invest in an actively managed portfolio comprised principally of securities from the S&P 500 Health Care Index. The Mulvihill ETF may also invest up to 25% of its net asset value in securities included in the S&P Global 1200 Health Care Index and the S&P/TSX Composite Health Care GICS® Index (that are not included in the S&P 500 Health Care Index). The Mulvihill ETF will also write call and put options on a portion of its portfolio to seek to generate investment returns and, in the case of put options, acquire securities at predetermined prices in a manner that reduces acquisition costs. The Manager may, from time to time in its discretion, hedge all or a portion of the foreign currency exposure of the Mulvihill U.S. Health Care Enhanced Yield ETF’s portfolio back to the Canadian dollar.

Distributions

The Fund expects to make distributions monthly that may consist of net income, net realized capital gains and/or return of capital, if any.

Eligibility

RRSPs, DPSPs, RRIFs, RESPs and TFSAs

Management Fees

The Fund pays a management fee of 0.65% of net asset value annually to Mulvihill Capital Management for acting as the Manager and the Investment Manager.

MER

The Management Expense Ratio (“MER”) is the sum of all operating expenses, including management and service fees but excluding portfolio transaction costs, expressed as a percentage of average net asset value.

Inception Date

02/14/2022

Manager

Mulvihill Capital Management Inc.

Documentation

Date:   All 2024 2023 2022		Type:   All Annual Information Form Distribution Notice Financial Report Fund Fact IRC Report Press Release Prospectus		Description
November 04, 2024		Press Release		XLVE: Declares Monthly Fund Distribution
October 25, 2024		Press Release		Announces Special Meeting
October 25, 2024		Prospectus		Notice of Special Meeting and Management Information Circular
October 02, 2024		Press Release		XLVE: Declares Monthly Fund Distribution
September 03, 2024		Press Release		XLVE: Declares Monthly Fund Distribution
August 30, 2024		Press Release		XLVE: Announces Semi-Annual Results 2024
August 29, 2024		Financial Report		2024 Semi-Annual Report
August 29, 2024		Financial Report		2024 Semi-Annual Report (French)
August 02, 2024		Press Release		XLVE: Declares Monthly Fund Distribution
July 03, 2024		Press Release		XLVE: Declares Monthly Fund Distribution
June 04, 2024		Press Release		XLVE: Declares Monthly Fund Distribution
May 03, 2024		Press Release		XLVE: Declares Monthly Fund Distribution
April 03, 2024		Press Release		XLVE: Declares Monthly Fund Distribution
March 27, 2024		Financial Report		2023 Annual Report
March 27, 2024		Financial Report		2023 Annual Report (French)
March 27, 2024		Press Release		XLVE: Announces Year End Results
March 05, 2024		IRC Report		IRC Report for Mulvihill U.S. Health Care Enhanced Yield ETF
March 05, 2024		Press Release		XLVE: Declares Monthly Fund Distribution
February 16, 2024		Fund Fact		ETF Facts
February 16, 2024		Fund Fact		ETF Facts (French)
February 15, 2024		Prospectus		Final Long Form Prospectus
February 15, 2024		Prospectus		Final Long Form Prospectus (French)
February 05, 2024		Press Release		XLVE: Declares Monthly Fund Distribution
January 03, 2024		Press Release		XLVE: Declares Monthly Fund Distribution
December 06, 2023		Press Release		XLVE: Declares Monthly Fund Distribution
November 02, 2023		Press Release		XLVE: Declares Monthly Fund Distribution
October 03, 2023		Press Release		XLVE: Declares Monthly Fund Distribution
September 05, 2023		Press Release		XLVE: Declares Monthly Fund Distribution
August 29, 2023		Financial Report		2023 Semi-Annual Report
August 29, 2023		Financial Report		2023 Semi-Annual Report (French)
August 29, 2023		Press Release		XLVE: Announces Semi-Annual Results 2023
August 02, 2023		Press Release		XLVE: Declares Monthly Fund Distribution
July 05, 2023		Press Release		XLVE: Declares Monthly Fund Distribution
June 06, 2023		Press Release		XLVE: Declares Monthly Fund Distribution
May 03, 2023		Press Release		XLVE: Declares Monthly Fund Distribution
April 04, 2023		Press Release		XLVE: Declares Monthly Fund Distributtion
March 31, 2023		Financial Report		2022 Annual Report
March 03, 2023		Press Release		XLVE: Declares Monthly Fund Distribution
February 15, 2023		Prospectus		Final Long Form Prospectus
February 02, 2023		Press Release		XLVE: Declares Monthly Fund Distribution
February 01, 2023		Press Release		XLVE: Mulvihill Launches Mulvihill U.S. Health Care Enhanced Yield ETF

Administration & Governance

Introduction

Mulvihill Capital Managent Inc. serves as the Manager and the Investment Manager of the Fund.

Manager

The Manager is responsible for providing or arranging for the provision of administrative services to the Fund including but not limited to:

• authorizing the payment of operating expenses incurred on behalf of the Fund,
• preparing financial statements and other accounting information,
• ensuring that unitholders are provided with annual and semi-annual reports and other reports as required by applicable law;
• ensuring the Fund complies with regulatory requirements;
• calculating and arranging for the payment of distributions;
• negotiating any contractual agreements with third-party providers of services to the Fund, including auditors, printers, registrar and transfer agent
• Overseeing and paying quarterly and annual redemptions;
• Maintaining the website and ongoing communication with investors.

The Management fee payable to the Manager includes any amount payable to the Investment Manager.

Investment Manager

The Investment Manager is responsible for making all investment decisions and managing the call option writing program in accordance with the investment objectives, strategies and restrictions of the Fund. Fees for the provision of investment management services are included in the management fee.

The Investment Manager has an asset mix committee consisting of senior members of the firm. The investment process for the Fund begins at the asset mix committee. Members of this committee meet monthly to examine macro-economic variables and relationships among dominant economic factors. This process culminates in an outlook for the various capital markets around the world and provides the Fundamental basis for Mulvihill’s long-term market outlook. These views are integrated into the investment decision making process at the portfolio management level. The asset mix committee of Mulvihill oversees investment decisions made by the portfolio managers of the Fund.

Independent Review Committee

The Fund has established an Independent Review Committee (“IRC”) in accordance with National Instrument 81-107 – Independent Review Committee for Investment Funds (“NI 81-107”) which is comprised of three members who are independent of the Manager. The mandate of the IRC is to review and provide its decisions to the Manager regarding any conflict of interest matters relating to its management of the Fund that the Manager has identified and brought to the committee.

A conflict of interest matter is a situation where a reasonable person would consider the Manager or an entity related to it to have an interest that may conflict with the Manager’s ability to act in good faith and in the best interests of the Funds and Securityholders. Click here for the IRC Report to Securityholders.

Click here to review members of the IRC.

Trustee and Custodian

Trustee: Mulvihill Capital Management Inc.
Custodian: RBC Investor & Treasury Services

Registrar and Transfer Agent

TSX Trust

Legal Counsel

Osler Hoskin & Harcourt LLP

Auditors

Deloitte & Touche LLP